"Ever since our failure in 2013 of the Assure trail...we never get any positive press on anything from the Cleveland Clinic or Nissan....I hope he doesn't feel he loses face by acknowledging all the positive things that have happened since that negative event."

Not true. 

CLEVELAND CLINIC PRESENTS RVX-208 DATA AT AMERICAN COLLEGE OF CARDIOLOGY (ACC) CONFERENCE IN WASHINGTON DC MARCH 31, 2014

Also, Daisuke Shishikura, who works in Steve Nicholls group in association w/ the Cleveland Clinic, presented at an Australian conference as well as ESC 2017 on "The effect of apabetalone on attenuated coronary atherosclerotic plaque: insights from the ASSURE trial."